AssetMark’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
AssetMark's HALO Position: Q3 2026 in Review
AssetMark reduced its Halozyme (HALO) stake by 4.4% in Q3 2026, selling an estimated $735K and leaving 166,721 shares worth $18.4M. The position accounts for 0.03% of the portfolio, ranked #389.
AssetMark first reported a position in HALO in Q4 2014 and has held it in 26 quarters since. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- AssetMark held 166,721 shares of Halozyme worth $18.4M as of Q3 2026.
- AssetMark sold 7,613 Halozyme shares in Q3 2026, an estimated $735K.
- Halozyme made up 0.03% of AssetMark's portfolio in Q3 2026, its #389 holding.
- AssetMark first reported a position in Halozyme in Q4 2014 and has held it in 26 quarters since.
- 636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.